Skip to main content
David Kupfer, MD, Psychiatry, Park City, UT

DavidJKupferMD

Psychiatry Park City, UT

Thomas Detre Professor of Psychiatry Professor of Neuroscience and Clinical and Translational Science at the University of Pittsburgh School of Medicine

Dr. Kupfer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kupfer's full profile

Already have an account?

  • Office

    3333 Meadows Dr
    Park City, UT 84060

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 1966 - 1967
  • Albert Einstein College of Medicine/Montefiore (New Rochelle)
    Albert Einstein College of Medicine/Montefiore (New Rochelle)Internship, Transitional Year, 1965 - 1966
  • Yale School of Medicine
    Yale School of MedicineClass of 1965

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1969 - Present
  • UT State Medical License
    UT State Medical License 2015 - 2026
  • PA State Medical License
    PA State Medical License 1973 - 2016
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Pittsburgh Magazine Castle Connolly, 2005-2008
  • Elected Member Institute of Medicine, 1990
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of a Person-Level Risk Calculator to Predict New-Onset Bipolar Spectrum Disorder in Youth at Familial Risk  
    David A. Brent, Rasim Diler, Dara Sakolsky, David J. Kupfer, JAMA

Press Mentions

  • Efforts to Describe Mental Illnesses Continue to Make Progress
    Efforts to Describe Mental Illnesses Continue to Make ProgressOctober 1st, 2019
  • Minerva's Sleep Drug Bests Ambien, Placebo in Dose-Finding Study
    Minerva's Sleep Drug Bests Ambien, Placebo in Dose-Finding StudyJune 24th, 2019
  • Minerva Neurosciences to Host Live Conference Call and Webcast with Key Opinion Leaders to Discuss Successful Insomnia Trial with Seltorexant
    Minerva Neurosciences to Host Live Conference Call and Webcast with Key Opinion Leaders to Discuss Successful Insomnia Trial with SeltorexantJune 23rd, 2019
  • Join now to see all

Grant Support

  • Research Career Development Institute For Bipolar DisorderNational Institute Of Mental Health2006–2012
  • Research Career Development Institute For PsychiatryNational Institute Of Mental Health2011
  • Sleep Research Network Conference SeriesNational Center For Research Resources2009–2011
  • Reducing Medical Risks In Individuals With Bipolar DisorderNational Institute Of Mental Health2008–2011
  • Research Career Development Institute For PsychiatryNational Institute Of Mental Health2004–2010
  • Medical Comorbidity, Medical Burden And Biopolar DisorderNational Institute Of Mental Health2006
  • Mhirc For The Study Of Mood And Anxiety DisordersNational Institute Of Mental Health2001–2005
  • Serotonin 1A Receptor &Metabolic Imaging In DepressionNational Institute Of Mental Health2001–2002
  • Core--PsychobiologyNational Institute Of Mental Health1996–2002
  • EEG Sleep Studies In Relation To Affective IllnessNational Institute Of Mental Health1991–2000
  • Mhcrc For The Study Of Affective DisordersNational Institute Of Mental Health1995–1999
  • Clinical Research Center Study Of Affective DisordersNational Institute Of Mental Health1985–1994
  • Small Instrumentation GrantNational Institute Of Mental Health1991
  • EEG Sleep Studies In Relation To Affective IllnessNational Institute Of Mental Health1985–1990
  • Maintenance Therapies In Recurrent DepressionNational Institute Of Mental Health1985–1988